Business
ASX rises 0.9pc, buoyed by Victoria easing, vaccine development – The Australian Financial Review
The Australian sharemarket closed at a seven-month high on Monday as Victoria eased lockdown restrictions and on news of progress towards a COVID-19 vaccine.
“The crisis support has been significant and the tapering of such will present a drag. That said, the fiscal pivot is meaningful in size and focus. This combined with liquid and willing, monetary support allows for some calibration of an earnings recovery and more normalcy in the cycle.”
CSL led the market gains and a broadly firmer health sector with the British National Health Service deputy chief medical officer Jonathan Van-Tam suggesting the Oxford University vaccine being manufactured by …
-
General7 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General23 hours agoFederal government funding extends cohealth GP services until July 2026
-
General10 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News22 hours agoFree flow of information vital to WHS – Proctor